Articles with public access mandates - Olivier BoucheratLearn more
Not available anywhere: 7
FOXM1 promotes pulmonary artery smooth muscle cell expansion in pulmonary arterial hypertension
A Bourgeois, C Lambert, K Habbout, B Ranchoux, S Paquet-Marceau, ...
Journal of Molecular Medicine 96, 223-235, 2018
Mandates: Heart and Stroke Foundation of Canada
Pulmonary arterial hypertension: New pathophysiological insights and emerging therapeutic targets
A Bourgeois, J Omura, K Habbout, S Bonnet, O Boucherat
The international journal of biochemistry & cell biology 104, 9-13, 2018
Mandates: Heart and Stroke Foundation of Canada
Identification of LTBP-2 as a plasma biomarker for right ventricular dysfunction in human pulmonary arterial hypertension
O Boucherat, T Yokokawa, V Krishna, S Kalyana-Sundaram, S Martineau, ...
Nature cardiovascular research 1 (8), 748-760, 2022
Mandates: Fonds de recherche du Québec - Santé
Epigenetic reactivation of transcriptional programs orchestrating fetal lung development in human pulmonary hypertension
P Chelladurai, C Kuenne, A Bourgeois, S Günther, C Valasarajan, ...
Science Translational Medicine 14 (648), eabe5407, 2022
Mandates: Canadian Institutes of Health Research, Fonds de recherche du Québec - Santé …
Hypusine signaling promotes pulmonary vascular remodeling in pulmonary arterial hypertension
SE Lemay, Y Grobs, C Romanet, S Martineau, M Salem, T Shimauchi, ...
American Journal of Respiratory and Critical Care Medicine, 2024
Mandates: Fonds de recherche du Québec - Santé
Intra-Airway Gene Delivery for Pulmonary Hypertension in Rodent Models
M Bisserier, O Boucherat, S Bonnet, L Hadri
Cardiac Gene Therapy: Methods and Protocols, 263-278, 2022
Mandates: US National Institutes of Health, American Heart Association
Articles in PresS. Am J Physiol Lung Cell Mol Physiol (March 26, 2010). doi: 10.1152/ajplung. 00333.2009
O Boucherat, ML Franco-Montoya, C Delacourt, J Martinovic, V Masse, ...
Mandates: Fonds de recherche du Québec - Santé, National Institute of Health and …
Available somewhere: 45
Novel insights on the pulmonary vascular consequences of COVID-19
F Potus, V Mai, M Lebret, S Malenfant, E Breton-Gagnon, AC Lajoie, ...
American Journal of Physiology-Lung Cellular and Molecular Physiology 319 (2 …, 2020
Mandates: Canadian Institutes of Health Research, Heart and Stroke Foundation of Canada
Translating research into improved patient care in pulmonary arterial hypertension
S Bonnet, S Provencher, C Guignabert, F Perros, O Boucherat, ...
American journal of respiratory and critical care medicine 195 (5), 583-595, 2017
Mandates: US National Institutes of Health
Standards and methodological rigor in pulmonary arterial hypertension preclinical and translational research
S Provencher, SL Archer, FD Ramirez, B Hibbert, R Paulin, O Boucherat, ...
Circulation research 122 (7), 1021-1032, 2018
Mandates: US National Institutes of Health, Fonds de recherche du Québec - Santé
Identification of long noncoding RNA H19 as a new biomarker and therapeutic target in right ventricular failure in pulmonary arterial hypertension
J Omura, K Habbout, T Shimauchi, WH Wu, S Breuils-Bonnet, E Tremblay, ...
Circulation 142 (15), 1464-1484, 2020
Mandates: Canadian Institutes of Health Research, Fonds de recherche du Québec - Santé …
Multicenter preclinical validation of BET inhibition for the treatment of pulmonary arterial hypertension
DE Van der Feen, K Kurakula, E Tremblay, O Boucherat, GPL Bossers, ...
American journal of respiratory and critical care medicine 200 (7), 910-920, 2019
Mandates: Netherlands Organisation for Health Research and Development, Royal …
DNA damage and pulmonary hypertension
B Ranchoux, J Meloche, R Paulin, O Boucherat, S Provencher, S Bonnet
International journal of molecular sciences 17 (6), 990, 2016
Mandates: Canadian Institutes of Health Research, Fonds de recherche du Québec - Santé …
Role for runt-related transcription factor 2 in proliferative and calcified vascular lesions in pulmonary arterial hypertension
G Ruffenach, S Chabot, VF Tanguay, A Courboulin, O Boucherat, F Potus, ...
American journal of respiratory and critical care medicine 194 (10), 1273-1285, 2016
Mandates: Canadian Institutes of Health Research, Fonds de recherche du Québec - Santé
Matrix metalloproteinase gene polymorphisms and bronchopulmonary dysplasia: identification of MMP16 as a new player in lung development
A Hadchouel, F Decobert, ML Franco-Montoya, I Halphen, PH Jarreau, ...
PloS one 3 (9), e3188, 2008
Mandates: National Institute of Health and Medical Research, France
Targeting histone acetylation in pulmonary hypertension and right ventricular hypertrophy
P Chelladurai, O Boucherat, K Stenmark, M Kracht, W Seeger, UM Bauer, ...
British journal of pharmacology 178 (1), 54-71, 2021
Mandates: German Research Foundation
HDAC6: a novel histone deacetylase implicated in pulmonary arterial hypertension
O Boucherat, S Chabot, R Paulin, I Trinh, A Bourgeois, F Potus, ...
Scientific reports 7 (1), 4546, 2017
Mandates: US National Institutes of Health, Canadian Institutes of Health Research …
Mitochondrial HSP90 accumulation promotes vascular remodeling in pulmonary arterial hypertension
O Boucherat, T Peterlini, A Bourgeois, V Nadeau, S Breuils-Bonnet, ...
American journal of respiratory and critical care medicine 198 (1), 90-103, 2018
Mandates: US National Institutes of Health, Canadian Institutes of Health Research …
Metabolic syndrome exacerbates pulmonary hypertension due to left heart disease
B Ranchoux, V Nadeau, A Bourgeois, S Provencher, É Tremblay, ...
Circulation research 125 (4), 449-466, 2019
Mandates: Canadian Institutes of Health Research, Natural Sciences and Engineering …
Implication of inflammation and epigenetic readers in coronary artery remodeling in patients with pulmonary arterial hypertension
J Meloche, MC Lampron, V Nadeau, M Maltais, F Potus, C Lambert, ...
Arteriosclerosis, thrombosis, and vascular biology 37 (8), 1513-1523, 2017
Mandates: Canadian Institutes of Health Research, Fonds de recherche du Québec - Santé …
Publication and funding information is determined automatically by a computer program